查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1539393

生物可吸收血管支架市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2031

Bioresorbable Vascular Scaffold Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 170 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於全球生物可吸收血管支架市場的綜合報告。本報告全面評估了主要市場動態，包括驅動因素、趨勢、機會和挑戰，並提供了有關市場結構的詳細見解。

關鍵見解

  • 生物可吸收血管支架市場規模（2024年）：3.39億美元
  • 預測市場規模（2031年）：5.928億美元
  • 全球市場成長率（2024-2031年年複合成長率）：8.3%

生物可吸收血管支架市場 - 研究範圍

生物可吸收血管支架是用於治療冠狀動脈疾病的創新醫療器材。這些支架目的是為血管提供臨時結構支撐，並隨著時間的推移逐漸溶解，無需永久性植入物。該市場面向醫院、心臟中心和專科診所，提供各種類型的支架，包括聚合物支架、金屬支架和混合支架。市場成長的驅動力是心血管疾病的日益普及、支架材料和設計的進步以及對微創手術的需求不斷成長。

推動市場成長的因素：

全球生物可吸收血管支架市場是由幾個關鍵因素推動的，包括心血管疾病的日益流行，以及對支持血管癒合的有效和臨時解決方案的需求。新型生物材料的開發和支架設計的改進等技術進步改善治療結果和病人安全。對微創手術的日益青睞也推動了對生物可吸收血管支架的需求。此外，增加研發投資以及目的是改善心血管治療的積極政府措施進一步推動了市場成長。

市場限制因素：

儘管成長前景廣闊，但生物可吸收血管支架市場面臨成本高且償付範圍有限的挑戰。生物可吸收血管支架所需的複雜製造流程和先進材料導致成本上升，並可能成為市場引進的障礙，特別是在新興國家。此外，市場還面臨與支架的長期性能和生物相容性相關的監管障礙和安全問題。應對這些挑戰需要持續創新、成本管理策略以及與醫療保健提供者和政策制定者的合作。

市場機會

由於技術創新和不斷擴大的應用，生物可吸收血管支架市場提供了巨大的成長機會。支架材料新興市場的發展，包括新型聚合物和生物活性塗料的開發，開闢新的市場擴張途徑。在周邊血管介入治療中日益採用生物可吸收血管支架，以及遠端監測和個人化治療計劃等數位健康技術的整合改善患者的治療效果並擴大市場範圍。策略合作夥伴關係、研發投資以及採用具有成本效益的解決方案對於利用這些機會並推動永續市場成長非常重要。

本報告解決的關鍵問題

  • 推動生物可吸收血管支架市場全球成長的關鍵因素是什麼？
  • 哪些支架類型和應用推動生物可吸收血管支架在各種醫療保健環境中的採用？
  • 由於技術進步，生物可吸收血管支架市場的競爭格局發生了什麼樣的變化？
  • 誰是生物可吸收血管支架市場的主要參與者？
  • 全球生物可吸收血管支架市場的新趨勢和未來前景如何？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 主要趨勢
  • 宏觀經濟因素
    • 世界產業展望
    • 全球 GDP 成長前景
    • 全球醫療保健支出前景
  • 新冠肺炎（COVID-19）影響分析
  • 預測因子 - 相關性和影響

第3章 增值見解

  • 產品採用率分析
  • 疾病流行病學
  • 技術評估
  • 監理狀況
  • 供應鏈分析
  • 主要交易和合併
  • PESTLE分析
  • 波特五力分析

第4章 價格分析，2024年

  • 主要亮點
  • 影響產品價格的主要因素
  • 價格分析：依產品分類
  • 區域定價與產品偏好

第5章 全球生物可吸收血管支架市場展望：實績（2019-2023）與預測（2024-2031）

  • 主要亮點
    • 市場數量（單位）預測
    • 市場規模（十億美元）和年成長率
    • 絕對數量的機會
  • 市場規模分析與預測（十億美元）
    • 過去的市場規模（十億美元）分析，2019-2023年
    • 2024-2031年目前市場規模（十億美元）分析與預測
  • 全球生物可吸收血管支架市場展望：產品
    • 簡介/主要發現
    • 過去的市場規模（十億美元）分析，依產品，2019-2023年
    • 2024-2031年當前市場規模（十億美元）和數量（單位）分析和預測，依產品
  • 市場吸引力分析：產品
  • 全球生物可吸收血管支架市場展望：應用
    • 簡介/主要發現
    • 2019-2023年過去的市場規模（十億美元）分析，依應用
    • 2024-2031年當前市場規模（十億美元）的分析與預測，依應用
  • 市場吸引力分析：應用
  • 全球生物可吸收血管支架市場展望：最終用戶
    • 簡介/主要發現
    • 2019-2023年歷史市場規模（十億美元）分析，依最終用戶
    • 2024-2031年目前市場規模（十億美元）的分析與預測，依最終用戶
  • 市場吸引力分析：最終用戶

第6章 全球生物可吸收血管支架市場展望：地區

  • 主要亮點
  • 2019-2023年歷史市場規模（十億美元）分析，依地區
  • 2024-2031年當前市場規模（十億美元）分析和預測：依地區
    • 北美
    • 歐洲
    • 東亞
    • 南亞/大洋洲
    • 拉丁美洲
    • 中東、非洲
  • 市場吸引力分析：地區

第7章 北美生物可吸收血管支架市場展望：實績（2019-2023）與預測（2024-2031）

第8章 歐洲生物可吸收血管支架市場前景：實績（2019-2023年）與預測（2024-2031年）

第9章 東亞生物可吸收血管支架市場展望：實績（2019-2023）與預測（2024-2031）

第10章 南亞和大洋洲生物可吸收血管支架市場前景：實績（2019-2023年）和預測（2024-2031年）

第11章 拉丁美洲生物可吸收血管支架市場展望：實績（2019-2023）與預測（2024-2031）

第12章 中東和非洲生物可吸收血管支架市場展望：實績（2019-2023）和預測（2024-2031）

第13章 競爭態勢

  • 2024年市佔率分析
  • 市場結構
    • 競爭強度圖：依市場劃分
    • 競爭儀表板
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • Meril Life Sciences Pvt. Ltd.
    • Zeus Company LLC
    • Biotronik
    • Abbott
    • MicroPort Scientific Corporation
    • Kyoto Medical
    • Elixir Medical（MedImpact Healthcare Systems, Inc.）
    • Cigna
    • B. Braun Melsungen AG
    • Boston Scientific Corporation
    • REVA Medical

第14章 附錄

  • 調查方法
  • 調查的先決條件
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP34715

Persistence Market Research has recently released a comprehensive report on the worldwide market for bioresorbable vascular scaffolds. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Bioresorbable Vascular Scaffold Market Size (2024E): US$339.0 Mn
  • Projected Market Value (2031F):US$592.8 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031):8.3%

Bioresorbable Vascular Scaffold Market - Report Scope:

Bioresorbable vascular scaffolds are innovative medical devices used in the treatment of coronary artery disease. These scaffolds are designed to provide temporary structural support to blood vessels and gradually dissolve over time, eliminating the need for permanent implants. The market caters to hospitals, cardiac centers, and specialized clinics, offering a range of scaffold types including polymer-based, metal-based, and hybrid scaffolds. Market growth is driven by increasing prevalence of cardiovascular diseases, advancements in scaffold materials and design, and rising demand for minimally invasive procedures.

Market Growth Drivers:

The global bioresorbable vascular scaffold market is propelled by several key factors, including the growing incidence of cardiovascular diseases and the need for effective and temporary solutions to support vessel healing. Technological advancements, such as the development of new biomaterials and improved scaffold designs, are enhancing treatment outcomes and patient safety. The rising preference for minimally invasive procedures is also driving demand for bioresorbable scaffolds. Additionally, increasing investments in research and development and favorable government initiatives aimed at improving cardiovascular care are further fueling market growth.

Market Restraints:

Despite promising growth prospects, the bioresorbable vascular scaffold market faces challenges related to high cost and limited reimbursement coverage. The complex manufacturing process and the advanced materials required for bioresorbable scaffolds contribute to higher costs, which can be a barrier to market adoption, especially in emerging economies. Moreover, the market encounters regulatory hurdles and safety concerns associated with long-term performance and biocompatibility of scaffolds. Addressing these challenges requires ongoing innovation, cost management strategies, and collaboration with healthcare providers and policymakers.

Market Opportunities:

The bioresorbable vascular scaffold market presents significant growth opportunities driven by technological innovations and expanding applications. Advances in scaffold materials, such as the development of novel polymers and bioactive coatings, are opening new avenues for market expansion. The increasing adoption of bioresorbable scaffolds in peripheral vascular interventions and the integration of digital health technologies, such as remote monitoring and personalized treatment plans, are enhancing patient outcomes and broadening market scope. Strategic partnerships, investment in R&D, and the introduction of cost-effective solutions are essential to capitalize on these opportunities and drive sustained market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the bioresorbable vascular scaffold market globally?
  • Which scaffold types and applications are driving bioresorbable scaffold adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the bioresorbable vascular scaffold market?
  • Who are the key players contributing to the bioresorbable vascular scaffold market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global bioresorbable vascular scaffold market?

Competitive Intelligence and Business Strategy:

Leading players in the global bioresorbable vascular scaffold market, including Abbott Laboratories, Boston Scientific Corporation, and Medtronic PLC, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced scaffolds with improved biocompatibility, strength, and degradation profiles. Collaborations with research institutions, healthcare providers, and regulatory agencies facilitate market access and promote technology adoption. Emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the evolving bioresorbable vascular scaffold landscape.

Key Companies Profiled:

  • Meril Life Sciences Pvt. Ltd.
  • Zeus Company LLC
  • Biotronik
  • Abbott
  • MicroPort Scientific Corporation
  • Kyoto Medical
  • Elixir Medical (MedImpact Healthcare Systems, Inc.)
  • Cigna
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • REVA Medical

Bioresorbable Vascular Scaffold Market Segmentation

By Product

  • Metal Bioresorbable Vascular Scaffold
  • Polymer Bioresorbable Vascular Scaffold

By Application

  • Peripheral Artery
  • Coronary Artery

By End User

  • Hospitals
  • Ambulatory Care Centers
  • Cardiac Centers

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Bioresorbable Vascular Scaffold Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Disease Epidemiology
  • 3.3. Technology Assessment
  • 3.4. Regulatory Landscape
  • 3.5. Supply Chain Analysis
  • 3.6. Key Deals and Mergers
  • 3.7. PESTLE Analysis
  • 3.8. Porter's Five Force Analysis

4. Price Analysis, 2024

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024-2031
  • 5.3. Global Bioresorbable Vascular Scaffold Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) Analysis, By Product, 2019-2023
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
      • 5.3.3.1. Metal Bioresorbable Vascular Scaffold
      • 5.3.3.2. Polymer Bioresorbable Vascular Scaffold
  • 5.4. Market Attractiveness Analysis: Product
  • 5.5. Global Bioresorbable Vascular Scaffold Market Outlook: Application
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
      • 5.5.3.1. Peripheral Artery
      • 5.5.3.2. Coronary Artery
  • 5.6. Market Attractiveness Analysis: Application
  • 5.7. Global Bioresorbable Vascular Scaffold Market Outlook: End User
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
    • 5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
      • 5.7.3.1. Hospitals
      • 5.7.3.2. Ambulatory Care Centers
      • 5.7.3.3. Cardiac Centers
      • 5.7.3.4. Others
  • 5.8. Market Attractiveness Analysis: End User

6. Global Bioresorbable Vascular Scaffold Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 7.4.1. Metal Bioresorbable Vascular Scaffold
    • 7.4.2. Polymer Bioresorbable Vascular Scaffold
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 7.5.1. Peripheral Artery
    • 7.5.2. Coronary Artery
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 7.6.1. Hospitals
    • 7.6.2. Ambulatory Care Centers
    • 7.6.3. Cardiac Centers
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. Europe Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 8.4.1. Metal Bioresorbable Vascular Scaffold
    • 8.4.2. Polymer Bioresorbable Vascular Scaffold
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 8.5.1. Peripheral Artery
    • 8.5.2. Coronary Artery
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 8.6.1. Hospitals
    • 8.6.2. Ambulatory Care Centers
    • 8.6.3. Cardiac Centers
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. East Asia Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 9.4.1. Metal Bioresorbable Vascular Scaffold
    • 9.4.2. Polymer Bioresorbable Vascular Scaffold
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 9.5.1. Peripheral Artery
    • 9.5.2. Coronary Artery
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 9.6.1. Hospitals
    • 9.6.2. Ambulatory Care Centers
    • 9.6.3. Cardiac Centers
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 10.4.1. Metal Bioresorbable Vascular Scaffold
    • 10.4.2. Polymer Bioresorbable Vascular Scaffold
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 10.5.1. Peripheral Artery
    • 10.5.2. Coronary Artery
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 10.6.1. Hospitals
    • 10.6.2. Ambulatory Care Centers
    • 10.6.3. Cardiac Centers
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Latin America Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 11.4.1. Metal Bioresorbable Vascular Scaffold
    • 11.4.2. Polymer Bioresorbable Vascular Scaffold
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 11.5.1. Peripheral Artery
    • 11.5.2. Coronary Artery
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 11.6.1. Hospitals
    • 11.6.2. Ambulatory Care Centers
    • 11.6.3. Cardiac Centers
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Bioresorbable Vascular Scaffold Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End User
  • 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024-2031
    • 12.4.1. Metal Bioresorbable Vascular Scaffold
    • 12.4.2. Polymer Bioresorbable Vascular Scaffold
  • 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2031
    • 12.5.1. Peripheral Artery
    • 12.5.2. Coronary Artery
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024-2031
    • 12.6.1. Hospitals
    • 12.6.2. Ambulatory Care Centers
    • 12.6.3. Cardiac Centers
    • 12.6.4. Others
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Meril Life Sciences Pvt. Ltd.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Zeus Company LLC
    • 13.3.3. Biotronik
    • 13.3.4. Abbott
    • 13.3.5. MicroPort Scientific Corporation
    • 13.3.6. Kyoto Medical
    • 13.3.7. Elixir Medical (MedImpact Healthcare Systems, Inc.)
    • 13.3.8. Cigna
    • 13.3.9. B. Braun Melsungen AG
    • 13.3.10. Boston Scientific Corporation
    • 13.3.11. REVA Medical

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations